Are psychedelics "miracle drugs"? If we compare them to the first Miracle Drug, the answer seems to be "yes".
Are psychedelics "miracle drugs"? If we compare them to the first Miracle Drug, the answer seems to be "yes".
Psychedelic drug stocks represent (by far) the best new opportunity in life sciences today. Institutional capital is flooding into the sector. But market analysts are asleep-at-the-wheel here.
Drug development or mental health clinics? We explore the benefits of both business strategies for investors in psychedelic stocks.
A Seattle doctor is suing the DEA for blocking access to psilocybin. Could this be the quickest road to psychedelic drug legalization?
Part of the benefit from psychedelic medicine may actually be a Placebo Effect. Find out why that is actually a GOOD thing.
The psychedelic drug industry continues to advance by leaps-and-bounds. But psychedelic drug stocks are well off recent highs. The sale is on!
This approval is a key step forward in the development of the company's iSTRYM digital therapeutics platform
If atai Life Sciences trades in the expected manner off its IPO, its market cap will quickly exceed the COMBINED market caps of all other psychedelic stocks.
This potential treatment opportunity was confirmed by the company's bioinformatics platform, PsyCollage
The Company expects to have ibogaine manufactured and in use for research by Q4.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now